Wang Xiaolin 4
4 · Revolution Medicines, Inc. · Filed Mar 3, 2023
Insider Transaction Report
Form 4
Wang Xiaolin
See Remarks
Transactions
- Award
Common Stock
2023-03-01+29,000→ 59,527 total - Award
Stock Option (Right to Buy)
2023-03-01+101,500→ 101,500 totalExercise: $26.50Exp: 2033-02-28→ Common Stock (101,500 underlying)
Footnotes (2)
- [F1]Includes 51,550 restricted stock units.
- [F2]One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2023 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.